Drug shortage proposal has "long tail" provision for 503Bs

An extensive drug shortage legislative package is being contemplated by House Energy & Commerce Committee leadership. Included in the outline of that package are provisions for a 180-day lag period for 503B outsourcing facilities to distribute drugs that were compounded due to a shortage.

“This ‘long tail’ is much needed and would create more of an economic incentive and greater efficiencies for 503Bs to fill gaps created by drug shortages,” said APC’s public policy director Savannah Cunningham.